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Although many transcription factors are known to
control important aspects of neural development,
the genome-wide programs that are directly regu-
lated by these factors are not known. We have
characterized the genetic program that is activated
by MEF2, a key regulator of activity-dependent
synapse development. These MEF2 target genes
havediverse functions at synapses, revealing abroad
role for MEF2 in synapse development. Several of the
MEF2 targets are mutated in human neurological
disorders including epilepsy and autism spectrum
disorders, suggesting that these disorders may be
caused by disruption of an activity-dependent gene
program that controls synapse development. Our
analyses also reveal that neuronal activity promotes
alternative polyadenylation site usage at many of
the MEF2 target genes, leading to the production of
truncated mRNAs that may have different functions
than their full-length counterparts. Taken together,
these analyses suggest that the ubiquitously
expressed transcription factor MEF2 regulates an
intricate transcriptional program in neurons that
controls synapse development.
INTRODUCTION
In the central nervous system (CNS), environmental stimuli regu-
late the development and function of neural circuits that underlie
behavior and cognition. Sensory experience, which leads to an
increase in neurotransmitter release onto individual neurons in
the CNS, promotes both the maturation of synapses and the
elimination of excess synapses within various neural circuits
during postnatal development (Hua and Smith, 2004) and drives
experience-dependent changes in synaptic connectivity that1022 Neuron 60, 1022–1038, December 26, 2008 ª2008 Elsevier Inunderlie learning and memory (Malinow and Malenka,
2002). One way increased neurotransmitter release triggers
changes in circuit connectivity is through new gene transcription.
Increased synaptic activity leads to calcium influx into the post-
synaptic cell, which activates calcium-dependent signaling
pathways that in turn regulate transcription factors within the
nucleus (Flavell and Greenberg, 2008). Several transcription
factors that mediate neuronal activity-dependent transcription
in neurons, including CREST and NeuroD, control early steps
of neural circuit development such as dendritic outgrowth
(Aizawa et al., 2004; Gaudilliere et al., 2004). Other activity-
regulated transcription factors, including CREB, SRF, NeuroD2,
and MEF2 family members, regulate later aspects of circuit
development by controlling synaptic development and function
(Barco et al., 2002; Etkin et al., 2006; Flavell et al., 2006; Ince-
Dunn et al., 2006; Ramanan et al., 2005; Shalizi et al., 2006).
Despite evidence that individual activity-regulated transcrip-
tion factors control specific aspects of neural circuit develop-
ment, the molecular mechanisms by which these factors
coordinate complex processes such as dendritic outgrowth
and synaptic development remain unclear. Previous studies
have for the most part identified the target genes of activity-
dependent transcription factors one at a time. Thus, the diversity
and complexity of the activity-regulated gene networks remain
to be investigated. For example, except perhaps for CREB,
which has been suggested to control hundreds of target genes
in neuronal cell lines (Impey et al., 2004), it is not known if a given
activity-regulated transcription factor regulates the expression
of several or perhaps hundreds of target genes in order to coor-
dinate a specific aspect of neural circuit development.
MEF2 family transcription factors are critical for the develop-
ment and function of many types of cells, including those found
in the musculoskeletal, cardiac, vascular, immune, and nervous
systems (Potthoff and Olson, 2007). In all of these contexts,
MEF2 transcriptional activity is tightly regulated by extracellular
stimuli. In neurons, MEF2 can be activated by neurotrophin
stimulation as well as calcium influx resulting from increased
neurotransmitter release at synapses. The neuronal activity-
dependent activation of MEF2 induces a program of genec.
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formed onto hippocampal neurons, cerebellar granule neurons,
and medium spiny neurons of the nucleus accumbens both
in vitro and in vivo (Barbosa et al., 2008; Flavell et al., 2006; Pulip-
paracharuvil et al., 2008; Shalizi et al., 2006). Furthermore, the
disruption of MEF2 expression in vivo in the hippocampus or
the nucleus accumbens results in deficits in behavioral plasticity
that are correlated with an increase in excitatory synapse number
(Barbosa et al., 2008; Pulipparacharuvil et al., 2008). Consistent
with a widespread role for MEF2 in synapse development, a similar
function for MEF2 has also been identified in species as distant
from mammals as the nematode C. elegans, where mef-2 nega-
tively regulates excitatory synaptic function at the cholinergic
neuromuscular synapse (Simon et al., 2008). Despite the impor-
tance of MEF2 as a mediator of activity-dependent synaptic
development in a wide range of species, the mechanisms by
which MEF2 orchestrates synaptic maturation are not known.
To examine how MEF2 coordinates synapse development in
response to neuronal activity, we have applied genome-wide
strategies to identify the full complement of target genes
that are controlled by MEF2 in neurons during the process
of activity-dependent synapse development. This approach of
understanding the function of a transcription factor through the
identification of its target genes has the potential to reveal mech-
anistic insights into transcription factor function that might be
missed by traditional loss-of-function experiments (through
RNAi or gene targeting). Using the loss-of-function approach, it
is often difficult to discern the direct effects of transcription factor
removal (resulting from altered expression of its direct target
genes) from the homeostatic effects that arise as an indirect
consequence of altering the expression of an entire transcrip-
tional program for several days.
In this study, we have used genome-wide approaches to iden-
tify 182 activity-dependent MEF2 target genes that regulate
a variety of different aspects of synaptic function including excit-
atory synapse weakening, excitatory synapse maturation, inhib-
itory synapse development and presynaptic vesicle release.
Mutations in several of the MEF2 target genes in the human
population result in an increased susceptibility to neurological
disorders such as epilepsy and autism spectrum disorders, sug-
gesting that these disorders may be caused at least in part by
disruption of activity-dependent gene networks that control
synapse development. One striking feature of the gene network
controlled by MEF2 is that in response to neuronal activity there
is a switch in polyadenylation site usage at many MEF2 target
genes that results in the activity-dependent production of trun-
cated mRNAs, many of which are predicted to have functions
that are distinct from their pre-existing, full-length counterparts.
Taken together, these experiments reveal new mechanisms by
which the activity-regulated transcription factor MEF2 coordi-
nates synaptic maturation during brain development.
RESULTS AND DISCUSSION
mRNA Expression Profiling Reveals Activity-Regulated
MEF2 Target Genes in Hippocampal Neurons
As a first step toward defining the activity-regulated MEF2-
dependent transcriptional program that controls synapseNdevelopment, we conducted an mRNA profiling experiment to
identify activity-regulated genes in hippocampal neurons under-
going synapse development. Hippocampal neurons harvested
from embryonic day 18 (E18) rats were grown in dissociated
cultures for 10 days in vitro (DIV). Hippocampal neurons at this
stage in their development are undergoing extensive changes
in both synapse number and synaptic strength, and we have
previously shown that the manipulation of MEF2 activity in these
cells alters the course of synapse development (Flavell et al.,
2006). To identify activity-regulated genes that might control
synapse development, we exposed neurons to elevated levels
of extracellular potassium chloride (KCl), which leads to
membrane depolarization and calcium influx via L-type voltage-
gated calcium channels. Using Affymetrix RAE230.2 microarrays
that include 30,000 probe sets, we identified 643 probe sets
that are upregulated after 1 or 6 hr of membrane depolarization
(Figure 1A). Importantly, a large number of the genes we identi-
fied are also activated by physiological levels of neurotransmitter
release in vivo, including c-fos, bdnf, gadd45b, nr4a1(or nur77),
egr1, arc, and many others (Majdan and Shatz, 2006).
To determine which of these activity-regulated genes might be
targets of MEF2 that control synapse development, MEF2
expression in neurons was reduced by introducing into the
neurons MEF2A- and MEF2D-specific shRNAs using lentiviral
vectors. By comparing the microarray results between the
control (scrambled shRNA expression) and MEF2 RNAi condi-
tions both before and after membrane depolarization, we
were able to identify a large set of genes whose expression is
altered as a result of MEF2 knockdown (1365 probe sets
identified; Figure 1B).
When the genes whose expression is downregulated in the
presence of MEF2 RNAi (at any time point) are pooled together
into a single gene set, there is a highly significant level of overlap
between this gene set and the activity-regulated gene set (151
overlapping probe sets, p < 0.0001, Fisher’s exact test; Fig-
ure 1D). The genes that are present in both gene sets are most
often decreased in their expression in the presence of MEF2
RNAi either one or six hours after membrane depolarization
(147/151, or 97%), but only rarely in unstimulated cells (25/151,
or 17%). Importantly, the majority (70%) of the activity-regulated
genes identified in our initial analysis are induced normally even
in the presence of MEF2 RNAi. This indicates that the knock-
down of MEF2 does not prevent activity-dependent gene
expression generally, but instead alters the expression of
a subset of activity-regulated genes.
It is possible that in the MEF2 loss-of-function experiments we
might have failed to identify particular activity-regulated MEF2
target genes because another transcription factor compensates
for the loss of MEF2 at the promoters of these genes. To circum-
vent this potential problem, we performed a MEF2 gain-of-
function experiment in hippocampal neurons at the time that
synapses are forming and maturing. For these experiments we
employed an inducible form of MEF2 in which the ligand binding
domain of the estrogen receptor (ER) is fused to the C terminus of
the constitutively active MEF2-VP16 fusion protein to generate
MEF2-VP16-ER. We have previously shown that in the absence
of the ER ligand 4-OH-Tamoxifen (4OHT), MEF2-VP16-ER
remains sequestered in the cytoplasm of hippocampal neuronseuron 60, 1022–1038, December 26, 2008 ª2008 Elsevier Inc. 1023
Neuron
Genomic Analysis of MEF2 TargetsC
D
A B
E
Figure 1. mRNA Profiling Analysis Reveals
Activity-Regulated MEF2 Target Genes
(A) 643 probe sets whose expression is upregulated
in E18 + 10 days in vitro (DIV) hippocampal neurons
upon KCl-mediated membrane depolarization were
identified by microarray analysis. Probe sets with
similar expression profiles were clustered together
using a Pearson correlation-based method, and the
expression levels of each of these probe sets (each
line represents a single probe set) are displayed as
a log2 ratio of their expression values after 1 or 6 hr
of KCl depolarization divided by their expression
value in unstimulated (0 hr) cells.
(B) 1365 probe sets whose expression is downregu-
lated in E18 + 10 DIV hippocampal neurons in the
presence of MEF2 RNAi were identified by microarray
analysis. These probe sets were clustered as in (A),
and expression levels are displayed as a log2 ratio
of their expression values in the presence of MEF2
RNAi divided by their expression values under control
conditions for each of the three time points examined.
(C) 251 probe sets whose expression is upregulated
by 4OHT application to MEF2-VP16-ER-expressing
hippocampal neurons at E18 + 10 DIV were identified
by microarray analysis. Probe sets were clustered as
in (A), and their levels of expression are displayed as
the log2 ratio of the expression value one or 2.5 hr
after 4OHT application divided by the expression
value prior to 4OHT application.
(D) Venn diagram showing the overlap of the probe
sets identified in the three gene sets shown in
(A)–(C). The levels of overlap between each of these
three gene sets are statistically significant (p <
0.0001 for all three comparisons, Fisher’s exact test).
(E) 304 probe sets whose expression is upregulated in forebrains of rats exposed to a novel environment for 3 hr were identified by microarray analysis. These
probe sets were clustered as in (A), and their levels of expression are displayed as the log2 ratio of their expression values in each individual animal divided by the
mean expression value of all control animals.and is inactive (Flavell et al., 2006). However, upon addition of
4OHT to the culture media MEF2-VP16-ER rapidly translocates
to the nucleus and activates MEF2-dependent transcription.
Hippocampal neurons were transduced with a lentivirus that
drives the expression of MEF2-VP16-ER and mRNA profiling
experiments were performed in the absence or presence of
4OHT using the same microarray platform described above. To
control for the nonspecific effects that 4OHT application or
MEF2-VP16-ER expression might have on gene expression,
we generated a lentivirus that expresses a DNA binding-deficient
control version of MEF2-VP16-ER (MEF2DDBD-VP16-ER) and
performed a parallel series of experiments using neurons trans-
duced with this virus. Probe sets that were upregulated in
response to 4OHT application in both MEF2-VP16-ER- and
MEF2DDBD-VP16-ER-expressing neurons were excluded from
further analysis.
We identified 251 probe sets that display increased expression
in neurons expressing MEF2-VP16-ER within 1 or 2.5 hr of 4OHT
application, but not in neurons expressing MEF2DDBD-VP16-ER
(Figure 1C). We asked whether these probe sets overlap with the
activity-regulated gene set or the set of genes whose expression
is downregulated in the presence of MEF2 RNAi. In both cases
there was a highly significant degree of overlap (75 and 55 probe
sets, respectively, p < 0.0001 for both comparisons, Fisher’s
exact test; Figure 1D), whereas the group of probe sets that1024 Neuron 60, 1022–1038, December 26, 2008 ª2008 Elsevier Incwere downregulated as a consequence of 4OHT application to
MEF2-VP16-ER-expressing neurons did not significantly overlap
with either of the other gene sets. Moreover, the MEF2-VP16-ER-
induced gene set did not overlap with genes whose expression is
increased in the presence of MEF2 RNAi or genes whose expres-
sion decreased upon KCl treatment. These data demonstrate
that the gain-of-function approach to MEF2 target gene identifi-
cation largely corroborates the loss-of-function approach.
Because the genes identified by the KCl depolarization, MEF2
RNAi and MEF2-VP16-ER experiments overlap in a manner that
is statistically significant and converge on a common set of
genes (Figure 1D), it is likely that the genes that are present in
more than one of these gene sets include the bona fide
activity-regulated MEF2 target genes in hippocampal neurons.
In our subsequent studies we only considered genes identified
in at least two of these three gene sets. This approach allows
for the possibilities that any single one of the approaches to
MEF2 target gene discovery might not have detected all of the
activity-regulated MEF2 target genes and that some of the genes
present in one particular gene set might not be bona fide activity-
regulated MEF2 target genes. We found that 221 probe sets
were present in at least two of these three gene sets (Table S1).
These probe sets map to 182 nonredundant genes that can be
confidently mapped in the rat genome and were therefore the
subject of further analysis. We randomly selected 15 of these.
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scription-quantitative PCR (RT-qPCR), and found that over
95% of the expression changes that were initially identified by
the microarray analysis were confirmed by RT-qPCR (Figures
S1–S3). These data indicate that the results from these microar-
ray experiments have a low false-discovery rate.
In Vivo Validation of mRNA Profiling Results
Because these initial experiments were performed using
cultured neurons, we examined whether the set of candidate
MEF2 target genes identified in these experiments are also
induced upon physiological stimulation of neurons in the intact
brain. To address this issue, we conducted a microarray analysis
to identify genes whose expression is increased in response to
sensory experience. To enhance levels of sensory experience,
rats that had been housed in a standard laboratory cage (control)
were placed for 3 hr in a novel cage containing objects of
different shapes and colors that induce exploratory behavior,
a procedure that has previously been shown to lead to new
gene transcription in neurons in the forebrain (novel environment;
Nithianantharajah and Hannan, 2006; Ramanan et al., 2005). We
identified 304 probe sets that display increased expression in the
forebrains of rats exposed to a novel environment (n = 6 animals
per condition; Figure 1E). These microarray results were also
validated by RT-qPCR (Figure S4). The candidate MEF2 target
genes characterized in cultured hippocampal neurons represent
a large fraction (16%, or 48/304) of the genes that are upregu-
lated in vivo in response to new sensory experience. Moreover,
22% (48/221) of the candidate MEF2 target genes that are upre-
gulated as a result of membrane depolarization of cultured
neurons are also induced by new sensory experiences in vivo,
a level that is far greater than would be expected by chance
alone (p < 0.0001, Fisher’s exact test). Consistent with these
results, a large number of the candidate MEF2 target genes
were also identified in a screen for genes whose expression is
increased in neurons in primary visual cortex in response to
visual stimulation (including c-fos, bdnf, gadd45b, nur77, egr1,
arc, and many others; Majdan and Shatz, 2006).
For individual genes, the fold increase in gene expression in
response to KCl treatment in vitro was highly correlated with
the fold increase in gene expression in response to exposure
to a novel environment (R2 = 0.36; p < 0.0001), although the level
of induction was consistently less robust in the novel environ-
ment experiment. This suggests that these two types of stimula-
tion activate gene expression through similar mechanisms.
However, the in vivo experiment appears to be less sensitive at
detecting activity-regulated changes in gene expression, likely
due to the heterogeneity of the cell population. Nevertheless,
because the gene expression changes detected by these two
approaches are highly correlated and overlap significantly, we
conclude that a large fraction of the candidate MEF2 target
genes identified in cultured neurons are induced in the brains
of animals exposed to novel sensory experiences.
ChIP-Chip to Identify MEF2-Binding Sites
in the Genome: Direct MEF2 Target Genes
The mRNA profiling experiments described above do not
address whether the genes identified are direct or indirectNtargets of MEF2. To determine which of these genes are directly
regulated by MEF2 and to provide additional confirmation that
our microarray experiments had indeed identified MEF2 target
genes, we performed chromatin immunoprecipitation followed
by tiling microarray analysis (ChIP-chip) to identify MEF2D-
binding sites within the regulatory regions of these 182 genes.
We developed ChIP conditions under which a MEF2D-specific
antibody immunoprecipitated DNA fragments of the nur77 prox-
imal promoter, a genomic region known to be bound by MEF2
(Figure S5; Youn et al., 2000). Preabsorption of the anti-MEF2D
antibody with the peptide antigen used to generate the antibody
blocked its ability to immunoprecipitate MEF2D proteins as well
as nur77 promoter DNA fragments (Figure S5). Because these
polyclonal anti-MEF2D antibodies might nonspecifically immu-
noprecipitate some DNA fragments and therefore lead to the
misidentification of MEF2D binding sites, we used the MEF2
peptide-absorbed anti-MEF2D antibody as a negative control
in all of the MEF2D ChIP-chip experiments described below.
We performed MEF2D ChIP-chip using a custom tiling micro-
array containing the genomic loci of the 182 genes identified in
our mRNA profiling experiments (including 10 kb 50 and 30 to
the genes). In these experiments, we also mapped the transcrip-
tional start sites (TSSs) within the putative MEF2 target genes by
performing ChIP-chip with an antibody that specifically recog-
nizes RNA polymerase II when bound to sites of transcription
initiation (Figures 2C and 2D; Mikkelsen et al., 2007). To identify
regions of MEF2D and RNA polymerase II occupancy, we devel-
oped a ‘‘peak-calling’’ algorithm that identified reproducible
regions of MEF2D or RNA polymerase II binding that were not
detected in negative control ChIP experiments conducted in
parallel. Binding of MEF2D to a subset of the genomic regions
identified through ChIP-chip was verified by subsequent ChIP-
qPCR experiments (92%, or 12 of the 13 regions tested;
Figure S6). These data indicate that the ChIP-chip approach
can be used to identify regions of MEF2D occupancy in the rat
genome.
Of the 182 genes examined, 78 (43%) have MEF2D binding
sites within the gene (including gene exons and introns) or within
10 kb 50 or 30 of the gene (Table S2). This represents a notable
increase over the background level of MEF2 binding detected
on a separate chromosomal tiling microarray that was carried
out as a control (8.8%) and MEF2 binding to arbitrarily selected
control genes that were included on our custom tiling microarray
(21%). These experiments demonstrate that the genes identified
in our expression analyses display an enrichment of nearby
regions of MEF2D occupancy and indicate that a large number
of the genes identified by the gene expression analyses are likely
to be direct targets of MEF2.
Bioinformatic Analyses of the Genomic Regions
of MEF2D Occupancy
To determine whether the genomic regions of MEF2D occu-
pancy that we identified serve as functionally important MEF2-
binding sites, we performed several analyses. First, we reasoned
that if these genomic regions play critical roles in gene regula-
tion, the nucleotide sequences within these regions should be
highly conserved through vertebrate evolution. Indeed,
compared to other sequences included on the tiling microarray,euron 60, 1022–1038, December 26, 2008 ª2008 Elsevier Inc. 1025
Neuron
Genomic Analysis of MEF2 TargetsA B
C
D
E
F
G
Figure 2. MEF2D ChIP-Chip Identifies MEF2-Binding Sites Surrounding the Candidate Target Genes
(A) Method for the identification of MEF2-binding sites by ChIP-chip. Sonicated DNA fragments enriched by MEF2D immunoprecipitation (yellow) will center on
the site of MEF2D binding (red). The intensity of the signals from several consecutive probe sets on the tiling microarray that correspond to this genomic region will
be identified as a peak of MEF2D binding.
(B) Example of a genomic region of MEF2D occupancy identified at the lgi1 gene locus. Raw data from one representative experiment are shown in the two
upper panels. The genomic region identified by our peak calling algorithm is shown in red, and the annotated RefSeq lgi1 mRNA (exons shown as blue boxes,
introns shown as blue lines with arrows that indicate direction of transcription) as well as level of evolutionary conservation within this genomic region are
shown below.
(C) An example of genomic regions of RNA polymerase II occupancy is shown as in (B). In addition, rat expressed sequence tags (ESTs) are shown to indicate
where unannotated mRNAs are likely to exist in this region of the rat genome.
(D) Distribution of the regions of RNA polymerase II occupancy relative to annotated RefSeq mRNAs. For this graph, the genomic loci of all genes were scaled to
40 kilobases (kb) and regions of RNA polymerase II occupancy are plotted according to their positions at or near the genes.1026 Neuron 60, 1022–1038, December 26, 2008 ª2008 Elsevier Inc.
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tionarily conserved nucleotides (p < 0.001, c2 test; Figure 2E).
Second, we asked whether a specific nucleotide sequence motif
was more commonly found within the MEF2D-bound genomic
regions than elsewhere in the rat genome. An unbiased analysis
of these genomic regions identified a ten-nucleotide motif that is
significantly enriched within these regions and can be found in
80% of the regions of MEF2D occupancy. This sequence
[(C/T)TA(T)4TAG] is nearly identical to the previously character-
ized MEF2 binding site, (C/T)TA(T/A)4TA(G/A), also termed the
MEF2 response element (MRE; Figure 2F; Potthoff and Olson,
2007). Compared to identical sequences found elsewhere in
the rat genome (this sequence is predicted to occur randomly
every 350 base pairs), the MREs found within regions of
MEF2D binding are significantly more likely to be conserved
through vertebrate evolution (p < 0.01, c2 test; Figure 2G), sug-
gesting that they are likely to be functionally important. Taken
together with the mRNA profiling experiments, these analyses
strongly suggest that MEF2, by binding to evolutionarily
conserved MREs near MEF2 target genes, directly regulates
the expression of a large set of activity-regulated genes in
neurons at the time that synapses are developing and maturing.
The sites of MEF2D binding were often (28% of the sites)
located close to the 50 ends of Reference Sequence (RefSeq)-
annotated mRNAs transcribed from the MEF2-regulated genes,
suggesting that these MEF2D binding sites form part of the prox-
imal promoters of these genes (within 2.5 kb; Figures 3A and 3B).
In addition to these binding sites, we also identified several
MEF2D binding sites (8% of the sites) that were located near
TSSs identified by RNA polymerase II ChIP-chip but were
not close to the 50 ends of any RefSeq-annotated mRNAs
(Figure 3C). It is likely that these MEF2D binding sites also
form part of the proximal promoters of these genes, but that
the mRNAs produced by these genes have not yet been fully
annotated.
The remaining 64% of the MEF2-binding sites that we identi-
fied using ChIP-chip occurred in regions of genes where there
was no evidence to suggest that transcription is initiated nearby
(within 2.5 kb; Figure 3D). We found that the magnitude of the
changes in mRNA expression observed in the gene expression
analyses (Figure 1) did not correlate with the distance of the
MEF2D-binding site from the TSS of the gene, suggesting that
both proximally and distally located MEF2D binding sites are
important for activity-dependent gene regulation. Consistent
with this conclusion, luciferase reporter experiments examining
the function of a MEF2-binding site located far upstream
(6.5 kb) of bdnf promoter I indicate that this MEF2 binding
site is critical for activity-dependent bdnf promoter I transcription
(Figures 3D and 3E). We conclude from these data that MEF2 can
regulate activity-dependent transcription by binding to evolu-
tionarily conserved MREs in proximal promoters as well as distal
enhancers at numerous MEF2 target genes.
Activity-Dependent Changes in Polyadenylation
Site Usage
One striking and unexpected feature of the activity-regulated
MEF2 genetic program was revealed by an investigation of alter-
native exon usage within this transcriptional program before and
after membrane depolarization of cultured neurons. Using the
microarray data that were collected from hippocampal neurons
before and after membrane depolarization, we performed
a search for genes that have one or more exon that displays
increased expression upon membrane depolarization while
other exon(s) do not (referred to as activity-dependent exon
usage). We identified 70 genes that fulfill this criterion,
including many of the newly identified MEF2 target genes. We
were able to validate numerous cases of activity-dependent
exon usage by performing RT-qPCR with primers that corre-
spond to the distinct exons within these genes (Figure 4A). Using
this approach, we also verified that the activity-dependent
changes in exon usage observed at several of these genes occur
in neurons in primary visual cortex in response to light stimulation
(Figure 4B). Taken together, these data indicate that the microar-
ray results reveal a genuine activity-dependent switch in exon
usage that occurs in vitro and in vivo at numerous genes,
including many MEF2 target genes.
Activity-dependent changes in exon usage could be due to
activity-dependent changes in the sites of transcriptional initia-
tion, changes in splicing, or alterations in transcriptional termina-
tion and polyA tail addition. Further analysis of the genes that
display an activity-dependent switch in exon usage revealed
that the activity-regulated exons within these genes are most
commonly found 50 to non-activity-regulated exons within the
same genes (78% of the time; Figure 4C). We also found that
the mRNAs that are produced from these genes in response to
membrane depolarization have polyA tails immediately 30 to
the sequences that correspond to the activity-regulated exons
within these mRNAs (Figure 4A). In addition, hexamers corre-
sponding to the known signal for polyA tail addition (AAUAAA
and closely related sequences; Tian et al., 2005) could be found
in their characteristic position 5–35 base pairs 50 to the sites of
polyA tail addition in these mRNAs (Figures 4D and 4E). These
results indicate that the activity-regulated exons within the
mRNAs that are expressed in response to membrane depolar-
ization are the terminal (30-most) exons within these mRNAs.
Thus, prior to stimulation, the mRNAs produced from these
genes are typically expressed at lower levels and are longer
[including additional exon(s) or a longer 30 UTR] than the mRNAs
(E) Histogram of the PhastCons evolutionary conservation scores within the entire custom tiling microarray (blue) or within the MEF2D-bound regions of the
custom tiling microarray (red). These distributions are bimodal, as the majority of the nucleotides in the rat genome are either nonconserved (close to zero) or
highly conserved (close to one). Asterisks are shown to indicate that these two distributions are significantly different (p < 0.001, c2 test).
(F) Logo of the MEF2 response element (MRE) that was identified as significantly enriched within the MEF2-bound genomic regions.
(G) Mean PhastCons scores of genomic regions surrounding each occurrence of the MRE in (F) are shown. The nucleotides corresponding to the MRE are
between the red lines, whereas the 400 nucleotides adjacent to each MRE surround the red lines. Mean PhastCons scores are shown for regions surrounding
MREs within the MEF2D-bound regions of the tiling microarry (black) or within random regions of the rat genome (cyan). The mean PhastCons scores of all the
nucleotides in the rat genome are also displayed (dotted black line). The PhastCons scores of the MREs within the MEF2D-bound regions are significantly higher
than those within random regions of the rat genome (p < 0.01, c2 test).Neuron 60, 1022–1038, December 26, 2008 ª2008 Elsevier Inc. 1027
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Figure 3. Location of the Genomic Regions of MEF2D Occupancy at MEF2-Regulated Genes
(A) Distribution of the regions of MEF2D occupancy along the MEF2-regulated genes, plotted as in Figure 2D.
(B) Example of a region of MEF2D occupancy that was identified within the proximal promoter of a MEF2-regulated gene (lgi1). The identified regions of MEF2D
and RNA polymerase II occupancy are shown in red, along with the annotated lgi1 gene and the level of evolutionary conservation within this genomic region.
(C) Example of a region of MEF2D occupancy that was detected at a site of RNA polymerase II occupancy upstream of the 50 end of a RefSeq annotated mRNA
(kcna4).
(D) Example of a region of MEF2D occupancy detected far upstream (6.5 kb) of the annotated transcriptional start site (TSS) of a MEF2-regulated gene (bndf).
This genomic region was cloned into the luciferase reporter constructs that are depicted below (MEF2-bound region is depicted as a red box).
(E) Normalized luciferase activity in lysates from E18 + 6 DIV hippocampal neurons that were transfected with the indicated luciferase reporter constructs
and either treated with elevated levels of extracellular KCl (blue) or left untreated (white). Data are shown as means ± standard error of the mean (SEM).
p < 0.01, two-factor analysis of variance (ANOVA); asterisks indicate statistical significance in pairwise comparison: p < 0.01, Bonferroni-Dunn post hoc test.1028 Neuron 60, 1022–1038, December 26, 2008 ª2008 Elsevier Inc.
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Figure 4. Neuronal Activity-Dependent
Alternative Polyadenylation Site Usage
(A) Upper: example of a gene (kif5c) that was iden-
tified through microarray analyses to display an
activity-dependent change in polyA site usage.
Rat ESTs that were sequenced with polyA tails
intact are shown at the 30 ends of the two kif5c
mRNAs that were independently measured on
the RAE230.2 microarray. Lower: RT-qPCR
confirmation of these microarray results for four
genes. Expression of each gene was measured
through two distinct primer sets that correspond
to different 30 ends of mRNAs produced by the
gene that were independently represented on
the microarray. Expression of these genes was
normalized to that of beta-3-tubulin and data are
shown as means ± SEM.
(B) RT-qPCR analysis conducted as in (A). Gene
expression in these experiments was measured
in neurons in primary visual cortex in both control
animals and animals that had been acutely
exposed to light stimulation. Expression of
these genes was normalized to that of beta-
3-tubulin and data are shown as means ± SEM.
Asterisk indicates significant increase in mRNA
expression (p < 0.05, t test) in animals
exposed to visual stimulation versus dark-reared
control animals. None of the full-length mRNAs
showed a significant change by these same
criteria.
(C) Changes in gene expression in response to
6 hr of KCl treatment for truncated and full-length
mRNAs produced by individual genes. All genes
that were identified through microarray analysis
as having disparate expression data between
two or more probe sets mapping to the same
gene are displayed. There is a strong bias for
the activity-regulated probe set to correspond
to the truncated mRNA (blue) rather than the
full-length mRNA (red). Inset: number of genes
belonging to these two categories.
(D) Distribution of polyA signal hexamers
surrounding the polyA regions. The exact loca-
tions of 19 polyA sites that in depth analyses indicated were high confidence sites of activity-dependent polyadenylation were used in this analysis. The polyA
signal hexamers that were acceptable in our analysis were those identified by Tian et al. (2005).
(E) Nucleotide density at the genomic regions surrounding the polyA sites that display activity-dependent use. Same polyA sites that were analyzed in (D) were
used in this analysis. Note that these genomic regions contain the characteristic A-rich region 50 to the polyA site and T-rich region 30 to the polyA site.
(F) Above: cartoon depicting a generic gene that has two distinct mRNA isoforms with different 30 ends. For four such genes, RT-PCR was performed with two
primer sets. For each gene, the primer sets shared the same forward primer in a 50 exon within the gene, but had different isoform-specific reverse primers, as
is shown. Using a cDNA template prepared from hippocampal neuron RNA, all RT-PCR reactions yielded products of the correct predicted length (below).
Note that two distinct splice forms (corresponding to two bands) of the short jip3 transcript were amplified; also note that the 30UTR of the truncated camk2d
isoform is especially long, so that this mRNA is larger than the full-length isoform even though it lacks several 30 protein-coding exons.that are produced upon membrane depolarization. Taken
together, these findings suggest that for a group of activity-
regulated genes, including many MEF2 target genes, there is
a switch in polyA site usage that favors the production of shorter
mRNAs that utilize internal sites of polyA tail addition.
Several additional lines of evidence support this conclusion.
First, using an RT-PCR-based approach, we verified that the
distinct mRNA isoforms produced by these genes while they
differ in their 30 ends share the same 50 exons (Figure 4F). This
demonstrates that the shortened mRNAs that are present after
stimulation belong to the same transcriptional units as the
full-length mRNAs that are present prior to membrane depolar-Neization. We also investigated RNA polymerase II pausing at the
activity-regulated genes that display activity-dependent polyA
site switching. Recent studies have revealed that the RNA
polymerase II complex pauses after polyA hexamers at the 30
ends of genes, leading to transcription termination, mRNA
cleavage and polyA tail addition (Gromak et al., 2006). Consis-
tent with these results, we detect an enrichment of RNA poly-
merase II at the 30 end of neuron-specific gene beta-3-tubulin
and an activity-dependent increase in RNA polymerase II occu-
pancy at the 30 end of the activity-regulated gene rgs2
(Figure 5A). However, at homer1 and other activity-regulated
genes that our analyses indicate display polyA site switching,uron 60, 1022–1038, December 26, 2008 ª2008 Elsevier Inc. 1029
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Figure 5. Features of PolyA Regions that Display Activity-Dependent Use
(A) Data from two independent ChIP experiments conducted with an antibody against the elongating form of RNA polymerase II are shown as levels of RNA
polymerase II enrichment at the indicated locations in the mouse genome, normalized to a negative control intergenic region that does not display RNA poly-
merase II occupancy. Note that analyses of microarray data (Figure 1) indicate activity-dependent polyA site switching at homer1, while polyA site switching
at sh3 multiple domains 4 (sh3md4), AU RNA binding protein/enoyl-Coenzyme A Hydratase (auh), and tubulin, gamma complex associated protein 4 (tubgcp4)
is indicated by additional expression analyses (data not shown). Data are shown as means ± SEM; asterisk indicates statistically significant increase in RNA
polymerase II occupancy for a given genomic region (p < 0.01, two-factor ANOVA).
(B) Logo of a novel motif that was identified as highly enriched in the regions surrounding the truncated polyA regions.
(C) RT-qPCR analysis of mRNA expression of the indicated truncated and full-length mRNAs. The fold induction of mRNA expression was analyzed in response to
6 hr of membrane depolarization in the absence or presence of the indicated inhibitors. Data from one representative experiment are shown as means ± SEM.
(D) Sets of genes identified through microarray analysis as displaying polyA site switching in response to different extracellular stimuli. Note that there is almost no
overlap between these different sets of genes.
(E) Model for activity-regulated polyadenylation site switching. At several MEF2 target genes, and other genes that display activity-dependent transcription,
neuronal activity promotes both increased levels of transcription and increased usage of internal polyadenylation sites, which leads to a robust increase in
the abundance of short mRNAs that differ from the full-length mRNAs produced in the absence of neuronal activity. The calcium-dependent activation of
MEF2 is mediated in large part through the calcineurin (CaN)-dependent dephosphorylation of MEF2 proteins, while calcium-dependent polyadenylation site
switching is mediated through signal transduction pathways that remain unknown. Note that although these processes are coupled at individual genes (like
the gene depicted in the model), the signaling pathways that lead to activity-dependent transcription and polyA site switching might be completely independent.activity-dependent RNA polymerase II pausing was detected at
the 30 end of the short mRNA rather than the 30 end of the full-
length mRNA (Figure 5A). This indicates that increased
neuronal activity leads to RNA polymerase II pausing in
genomic regions surrounding the sites of activity-dependent
polyA tail addition, which likely leads to the cleavage of pre-
mRNAs in this region, followed by the addition of a polyA
tail. Taken together with the analyses described above, these
data provide strong evidence that neuronal activity leads to
polyA site switching at a number of activity-regulated genes,
including many MEF2 target genes.1030 Neuron 60, 1022–1038, December 26, 2008 ª2008 Elsevier IncMolecular Mechanisms Underlying Activity-Dependent
polyA Site Switching
We took several approaches to begin to identify the molecular
mechanisms by which neuronal activity triggers polyA site
switching. Although our bioinformatic analyses indicated that
the genomic regions surrounding the sites of activity-regulated
polyA tail addition have features of typical sites of polyA tail
addition (including the polyA signal hexamer, AATAAA, and
closely related sequences; Figures 4D and 4E), we performed
an unbiased search for additional nucleotide sequence motifs
that were specifically enriched within the genomic regions where.
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occur. This analysis resulted in the identification of a novel motif
that was present in many of these genomic regions (42%;
TTGTTGGG; Figure 5B), but was only rarely found in the genomic
regions that surround non-activity-regulated sites of polyA tail
addition (8%). While the function of this motif is not yet clear,
our bioinformatic analyses suggest that this sequence motif
may play an important role in directing activity-dependent poly-
adenylation to specific sites, perhaps by promoting activity-
dependent pausing of RNA polymerase II in these specific
genomic regions, leading to mRNA cleavage and polyA tail
addition.
To determine how neuronal activity might trigger RNA poly-
merase II pausing and polyA tail addition at these genes, we
monitored the expression of both the short and full-length
mRNAs produced by several of the genes that display activity-
dependent polyA site switching (including several MEF2 target
genes) and performed a pharmacological screen to identify
agents that altered the activity-dependent expression of these
mRNAs. None of the pharmacological agents applied (15 total)
successfully dissociated the process of activity/MEF2-depen-
dent transcription from the process of activity/MEF2-dependent
polyA tail addition at any of the genes examined (Figure 5C and
data not shown). This result suggests that these two processes
might be coupled. However, we note that MEF2 is not the only
transcription factor that can couple activity-dependent transcrip-
tion to activity-dependent polyA site switching, as 41 activity-
regulated genes that are not regulated by MEF2 also display
a switch in polyA site usage in response to membrane depolariza-
tion. Although we were unable to dissociate the processes of
activity-dependent transcriptional initiation and polyA site
switching, we were able to identify several agents (the calcium
chelator EGTA, the L-type voltage-gated calcium channel
(L-VGCC) antagonist nimodipine, and the cAMP-regulated
protein kinase (PKA) inhibitor H89) that prevented the activity-
dependent transcription/polyadenylation of each of the short
mRNAs that were examined. These data indicate that the
activity-dependent induction of truncated mRNAs is due to the
coupling of activity-dependent transcription and activity-depen-
dent polyA site switching at select genes, and requires calcium
influx through L-VGCCs, as well as the activation of PKA
(Figure 5C).
PolyA Site Switching in Other Transcriptional Programs
In considering the potential functions of activity-dependent
polyA site switching, we reasoned that this mechanism might
exist to promote the expression of short mRNA transcripts that
are important for activity- and MEF2-dependent synapse devel-
opment. Consistent with this idea, when we monitored the
expression of several of these short mRNAs, we found that appli-
cation of other extracellular factors that do not promote activity-
and MEF2-dependent synapse development in hippocampal
neurons (such as BDNF, NT-4, EGF, and forskolin) does not
lead to polyA site switching at the same set of genes that display
this switch in response to increased neuronal activity (data not
shown).
Nevertheless, we reasoned that extracellular stimulus-
dependent polyA site switching might be a general mechanismNused by cells in a variety of different contexts to alter gene func-
tion in response to changes in their environment. To determine
whether application of other extracellular factors to cells leads
to polyA site switching at genes that do not display this switch
in response to neuronal activity, we analyzed a number of
publicly available microarray data sets. We were able to identify
genes that displayed polyA site switching in response to: (1) EGF
application to astrocytes, (2) interleukin-2 application to T cells,
and (3) anti-IgM and CpG coapplication to B cells. Furthermore,
while this paper was under review, a separate study showed that
stimulation of several types of immune cells also causes polyA
site switching, which leads to the production of shortened
mRNAs (Sandberg et al., 2008). The sets of genes that
display polyA site switching in these different cellular contexts
are almost completely nonoverlapping (Figure 5D). These data
indicate that a wide variety of extracellular factors can trigger
polyA site switching, but the specific genes that display this
switch vary depending on the cell type and the extracellular
stimulus.
Functional Consequences of Activity-Dependent
PolyA Site Switching
Activity-dependent polyA site switching is likely to play a wide-
spread role in the regulation of neuronal gene expression (see
Table 1 for full list of genes that display this switch). This gene
regulatory mechanism significantly alters the functions of
10% of the mRNAs that are transcribed from MEF2 target
genes in response to increased neuronal activity. The shortened,
activity-regulated mRNAs are often predicted to encode proteins
that are functionally distinct from the proteins encoded by the
full-length mRNAs produced by the same gene. For instance,
these mRNAs are predicted to encode scaffolding proteins
that lack one or more of their C-terminal protein-protein interac-
tion domains (homer1, jip3), signaling enzymes that lack
C-terminal regulatory domains (casein kinase I epsilon, arhgef9)
and transport proteins that lack their ability to transport dendritic
mRNAs (kif5c; Kanai et al., 2004). In the case of homer1, the
shortened mRNA encodes a dominant-negative form of homer1
that disrupts full-length homer1 function and restricts excitatory
synapse number (Sala et al., 2003).
For other genes, the only difference between the shortened,
activity-regulated mRNAs and the full-length mRNAs is that the
shortened mRNAs lack a portion of their 30UTRs. Interestingly,
a recent study showed that the truncation of 30 UTRs as a result
of polyA site switching removes microRNA binding sites that
repress mRNA translation (Sandberg et al., 2008). Thus, while
these mRNAs are predicted to encode the same proteins as
the full-length mRNAs, they likely lack elements within their 30
UTRs that might specify where and when the mRNAs will be
translated.
Based on the homer1 example, as well as our analyses of the
sequences of the other newly identified truncated mRNAs, we
hypothesize that stimulus-dependent polyA site switching
might be a general mechanism used to alter gene function in
response to changes in a cell’s extracellular environment. It is
possible that stimulus-regulated transcriptional programs
such as the activity-dependent MEF2 genetic program
commonly use polyA site switch mechanisms to interfere witheuron 60, 1022–1038, December 26, 2008 ª2008 Elsevier Inc. 1031
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Genomic Analysis of MEF2 TargetsTable 1. Genes that Display a Neuronal Activity-Dependent Switch in Polyadenylation Site Usage
MEF2- and Activity-Regulated Genes
Common Name Description
JSAP1 JNK/SAPK-associated protein 1
Odz2 odd Oz/ten-m homolog 2 (Drosophila)
Arhgef9 Cdc42 guanine nucleotide exchange factor (GEF) 9
Csnk1e casein kinase 1, epsilon
Vesl-1; HOMER1F homer homolog 1 (Drosophila)
Pcdh9_predicted protocadherin 9 (predicted)
Omp25 synaptojanin 2 binding protein
Pkib protein kinase (cAMP dependent, catalytic) inhibitor beta
LOC299907 similar to Ext1
LOC498145 similar to RIKEN cDNA 2810453I06
Septin 11 septin 6 (predicted)
Rybp_predicted RING1 and YY1 binding protein (predicted)
Rinzf zinc finger and BTB domain containing 10
RGD1566117_predicted similar to hypothetical protein FLJ23033
RGD1311381_predicted similar to hypothetical protein FLJ20037 (predicted)
Klf6 core promoter element binding protein
RGD1308432_predicted similar to cDNA sequence BC020002 (predicted)
Tcf4 transcription factor 4
Activity-Regulated Genes (not MEF2 Regulated)
Usp9x_predicted similar to ubiquitin specific protease 9, X-linked (fat facets-like, Drosophila)
Syncrip synaptotagmin binding, cytoplasmic RNA interacting protein (predicted)
Dab1 disabled homolog 1 (Drosophila)
Arih1 ariadne ubiquitin-conjugating enzyme E2 binding protein homolog 1 (Drosophila) (predicted)
HSPG syndecan 2
Camk2d calcium/calmodulin-dependent protein kinase II, delta
Rnf153 ring finger protein 153 (predicted)
Rab21 RAB21, member RAS oncogene family
Impad1 inositol monophosphatase domain containing 1
Kif5c_predicted kinesin family member 5C (predicted)
Mbd1 methyl-CpG binding domain protein 1 (predicted)
LOC363153 similar to protein phosphatase 1, regulatory (inhibitory) subunit 1C; thymocyte ARPP;
RGD1562438_predicted similar to amyloid beta (A4) precursor protein-binding, family B, member 2
Gpr177 CG6210-like
Ppp1r2 protein phosphatase 1, regulatory (inhibitor) subunit 2
Zfp68_predicted zinc finger protein 68 (predicted)
Idb4 inhibitor of DNA binding 4
Pabpn1 poly(A) binding protein, nuclear 1
Usp19 ubiquitin specific protease 19
Ssr1 signal sequence receptor, alpha (predicted)
Txnl; MGC114276 thioredoxin-like (32 kD)
Pofut2_predicted protein O-fucosyltransferase 2 (predicted)
Spred1 sprouty protein with EVH-1 domain 1, related sequence (predicted)
Csrp2bp_predicted cysteine and glycine-rich protein 2 binding protein (predicted)
Vcip135 valosin-containing protein (p97)/p47 complex-interacting protein 135
Cachd1_predicted cache domain containing 1 (predicted)
Josd3 josephin domain containing 3
Pafah1b1 platelet-activating factor acetylhydrolase, isoform Ib, alpha subunit 45kDa
Ahctf1_predicted AT hook containing transcription factor 1 (predicted)1032 Neuron 60, 1022–1038, December 26, 2008 ª2008 Elsevier Inc.
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MEF2- and Activity-Regulated Genes
Common Name Description
Degs degenerative spermatocyte homolog (Drosophila)
Cggbp1_predicted CGG triplet repeat binding protein 1 (predicted)
AIP1; Alix programmed cell death 6 interacting protein
Rptpk protein tyrosine phosphatase, receptor type, K, extracellular region
Ppp2r2a protein phosphatase 2 (formerly 2A), regulatory subunit B (PR 52), alpha isoform
Rnpc2 RNA-binding region (RNP1, RRM) containing 2 (predicted)
RGD1309388_predicted similar to DIP13 alpha (predicted)
RGD1307879_predicted similar to hypothetical protein D10Ertd438e (predicted)
RGD1309054_predicted similar to FKSG26 protein (predicted)
RGD1559923_predicted similar to chromosome 14 open reading frame 35
Psme4 proteasome (prosome, macropain) activator subunit 4
RGD1310651_predicted similar to hypothetical protein MGC20460 (predicted)
These genes are divided into two groups. The 18 MEF2- and activity-regulated genes listed were included among the 182 MEF2 target genes that we
identified, while the 41 activity-regulated genes (not MEF2 regulated) that are listed were included among the 643 activity-regulated genes identified in
our study, but did not display evidence of MEF2-dependent regulation.or alter the function of preexisting proteins. Because new gene
transcription does not necessarily lead to the disappearance of
stably expressed proteins, the production of shortened, domi-
nantly interfering or activating forms of these proteins may
provide an efficient way to acutely disrupt or alter the function
of existing proteins. Given that the remodeling of synapses
likely requires the destabilization of existing structures (through
activity-regulated genes like homer1a), the polyA site switch
mechanism may have evolved to generate truncated proteins
and/or mRNAs that can acutely reverse cellular processes
such as synapse development.
MEF2 Target Genes that Function at Synapses
to Control Synaptic Remodeling
A striking feature of the group of MEF2 target genes that we have
identified is that this set of genes displays enriched expression
specifically within the CNS (based on comparisons to GNF Atlas
2 expression data; Su et al., 2004; Table S3) and a large number
of these genes encode proteins that function at neuronal
synapses (p = 2.14 3 107, enrichment for Synaptic Transmis-
sion GO category, Ingenuity Pathway Analysis; Figure 6). In
support of the recently described function of MEF2 in restricting
the number of excitatory synapses that form on neurons, many
Nucleus Synapse
Figure 6. MEF2 Target Genes that Function
at the Synapse and in the Nucleus
The list of newly identified MEF2 target genes was
enriched for genes that encode transcriptional
regulators and for genes that encode proteins
that function at the synapse. Several examples
of these types of genes are shown. See main
text for additional details.Neuron 60, 1022–1038, December 26, 2008 ª2008 Elsevier Inc. 1033
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Genomic Analysis of MEF2 Targetsof the MEF2 targets we have identified are known to contribute to
the weakening/loss of excitatory synapses by regulating
different aspects of signal transduction on the postsynaptic
side of the synapse: Homer1a is involved in the disassembly of
postsynaptic scaffolding complexes (Sala et al., 2003), while
activity-regulated cytoskeletal protein (Arc) and c-jun N-terminal
kinase (Jnk) promote AMPAR removal from the postsynaptic
membrane (Chowdhury et al., 2006; Zhu et al., 2005). The
MEF2 target genes also include three members of the delta
subfamily of protocadherins (protocadherins 9, 10, and 17),
which have recently been shown to restrict the number of
synapses formed onto neurons by promoting the internalization
of N-cadherin, a synaptic adhesion molecule that stabilizes
excitatory synapses (Yasuda et al., 2007). Finally, increased
expression of the postsynaptically localized potassium
channels encoded by the MEF2 target genes kcna1 and kcna4
would also be predicted to decrease excitatory postsynaptic
strength, as dendritic areas of increased potassium channel
conductance display more limited excitatory postsynaptic
potential (EPSP) summation (Lujan et al., 2003; Raab-Graham
et al., 2006). The finding that each of these genes is a MEF2
target indicates that MEF2 restricts synapse number through
multiple mechanisms that together contribute to synapse weak-
ening and synapse elimination.
The application of genomic strategies to identify MEF2 targets
at the time that synapses are forming has also revealed new and
unexpected roles for MEF2 in synapse biology. Unexpectedly,
several of the MEF2 target genes encode proteins known to
localize to the postsynaptic side of excitatory synapses and
promote synaptic strengthening: leucine-rich glioma-inactivated
1 (Lgi1) promotes AMPAR insertion into the postsynaptic
membrane by binding to its transmembrane receptor (Fukata
et al., 2006); adenylyl cyclase 8 mediates calcium-dependent
cAMP production necessary for calcium-dependent synaptic
strengthening (Wang et al., 2003); and Bdnf is known to enhance
excitatory synaptic strength though a variety of mechanisms, for
instance by acting as a retrograde signal that enhances presyn-
aptic release (Zhang and Poo, 2002). One possible explanation
for the coordinated expression of MEF2 target genes with antag-
onistic functions (synaptic weakening versus strengthening) is
that the activation of MEF2 might lead to a decrease in the total
number of synapses formed onto cells through one group of target
genes (e.g., homer1a, arc, kcna1, etc.) and at the same time lead
to the strengthening of a separate subset of synapses through
a separate group of target genes (e.g., adenylyl cyclase 8, bdnf,
etc.). In fact, it is known that synapse elimination and synaptic
potentiation (of other synapses) occur concurrently within indi-
vidual cells during synapse development (Chen and Regehr,
2000). Further experiments will be necessary to determine the
specific synapses at which each of these different MEF2 target
genes functions.
Several of the genes identified in our screen for MEF2 target
genes encode proteins that function postsynaptically at inhibi-
tory synapses, providing the first evidence that MEF2 regulates
inhibitory synaptic function. The Cdc42 guanine nucleotide
exchange factor (GEF) Arhgef9 and the actin organizing mole-
cule Mena both regulate the actin cytoskeleton in order to
promote the clustering of gephyrin, a scaffolding protein that is1034 Neuron 60, 1022–1038, December 26, 2008 ª2008 Elsevier Incspecifically found at inhibitory synapses (Giesemann et al.,
2003; Papadopoulos et al., 2007), while Bdnf is critical for
activity-dependent inhibitory synapse formation (Rutherford
et al., 1997). The finding that these genes are also included
among the MEF2 target genes indicates that MEF2 may play
a positive role in promoting inhibitory synapse development in
addition to its effects on excitatory synapse development.
Consistent with this idea, recent studies from our laboratory
have identified an activity-regulated transcription factor,
NPAS4 (not present on the RAE230.2 microarrays used in this
study), that plays a key role in the formation of inhibitory
synapses onto excitatory neurons and appears to be a direct
target of MEF2 (Lin et al., 2008; and data not shown).
The activity-dependent activation of MEF2 within a neuron
also triggers the induction of target genes that regulate the
presynaptic outputs of the neuron. For example, mUNC13,
mLin7A, and rgs2 each encode proteins that enhance synaptic
vesicle release. Moreover, the neuropeptides somatostatin and
adenylate cyclase activating polypeptide 1 (ADCYAP1, or
PACAP), both encoded by activity-regulated MEF2 target genes,
are known to be secreted from presynaptic sites and to modulate
excitatory synaptic transmission (Boehm and Betz, 1997;
Roberto et al., 2001).
These data demonstrate that in response to neuronal activity
MEF2 activates target genes that regulate multiple aspects of
neural circuit development and function. In addition to activating
genes that weaken excitatory synaptic inputs formed onto the
MEF2-expressing neuron, MEF2 also activates additional
groups of target genes that strengthen select excitatory synaptic
inputs, remodel inhibitory synaptic inputs and regulate the
presynaptic outputs of the MEF2-expressing neuron. Further
experiments will be necessary to determine if these MEF2
targets are all expressed together in the same neurons or, alter-
natively, if distinct subsets of these target genes are expressed in
different subsets of neurons (e.g., CA3 versus CA1 pyramidal
neurons). Nevertheless, these findings indicate that in response
to an increase in neural circuit activity, the activation of MEF2
within individual neurons in the circuit leads to the induction of
an extensive genetic program that likely plays a central role in
the process of experience-dependent synaptic development,
refinement and plasticity.
MEF2 Target Genes that Function within the Nucleus
Another group of genes that is statistically overrepresented
among the MEF2 target genes encode proteins that function
within the nucleus to regulate transcription (p = 1.75 3 1031,
enrichment for Transcription GO category, Ingenuity; Figure 6).
Among these transcriptional regulators are several molecules
(e.g., c-fos, fosB, early growth response 1 [egr1], egr3, nur77,
histone deacetylase 5 [hdac5], and mef2a itself) that have been
documented to play a critical role in synapse development and
plasticity, although for the most part the target genes of these
transcription factors remain to be identified (Flavell et al., 2006;
Fleischmann et al., 2003; Hiroi et al., 1997; Jones et al., 2001;
Li et al., 2007; Renthal et al., 2007; Shalizi et al., 2006). The iden-
tification of these genes as MEF2 targets suggests that MEF2
induces the expression of a set of regulatory factors that work
together with MEF2 to control synaptic function. Consistent.
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Genomic Analysis of MEF2 TargetsTable 2. MEF2 Target Genes Related to Epilepsy and Autism Spectrum Disorders in Humans
Disease Gene Name Gene Symbol
Reference
(Pubmed ID)
Epilepsy leucine-rich, glioma inactivated 1 lgi1 11810107
Epilepsy potassium voltage-gated channel, shaker-related subfamily, member 1 kcna1 10414318
Epilepsy Cdc42 guanine nucleotide exchange factor (GEF) 9 arhgef9 15215304
Angelman syndrome ubiquitin protein ligase E3A ube3a 8988171
Angelman syndrome solute carrier family 9 (sodium/hydrogen exchanger), member 6 slc9a6 18342287
Autism/epilepsy protocadherin 10 Pcdh10 18621663
Autism/epilepsy chromosome 3, open reading frame 58 c3orf58 18621663with this idea, a number of the MEF2 targets are known to
enhance MEF2 activity (IFRD1 and MEF2A; Micheli et al., 2005)
whereas other targets interact with MEF2 and inhibit its tran-
scriptional activity (the putative histone demethylase Jumonji
and the histone deacetylase HDAC5; Kim et al., 2005; McKinsey
et al., 2000).
MEF2 Target Genes in Neurological Disease
The importance of the MEF2 transcriptional program for neural
circuit development and function in humans is highlighted by
the fact that mutations in several of the MEF2 targets in humans
give rise to neurological disorders. Mutations in the human or-
thologs of the MEF2 target genes lgi1, kcna1, and arhgef9 result
in an imbalance between synaptic excitation and inhibition that
leads to epilepsy (Table 2 and references therein). In addition,
mutations in the human orthologs of the MEF2 target genes
ube3a and solute carrier 9,member 6 (slc9a6) are known to cause
Angelman syndrome, a disorder characterized by mental retarda-
tion and increased susceptibility to seizures. Finally, two of five
mutations that were recently shown to give rise to autism and
epilepsy in families in which parents share ancestors occur within
the putative regulatory regions of protocadherin 10 and c3orf58
(Morrow et al., 2008). Protocadherin 19, which is closely related
to protocadherin 10, has also recently been linked to epilepsy
and mental retardation in several families (Dibbens et al., 2008).
The symptoms of epilepsy, Angelman syndrome and autism
are typically manifested in the first years of life during which
sensory experience regulates synapse development and func-
tion. Thus, our finding that MEF2, a transcription factor activated
by sensory experience, regulates activity-dependent synaptic
development and induces the expression of a set of genes,
several of which are mutated in disorders of human cognition,
suggests that a common mechanism of these disorders may
be the disruption of the activity-dependent MEF2-regulated
gene expression program. This also raises the possibility that
human genetic studies combined with the characterization of
cell type-specific transcriptional programs that regulate synapse
development and maturation (like the activity-regulated MEF2
transcription program) may provide an enhanced understanding
of the molecular basis of epilepsy and autism.
Concluding Remarks
In the CNS, sensory stimulation leads to the activation of MEF2
and several other activity-regulated transcription factors that in
turn activate programs of gene expression necessary forNesynapse development and remodeling (Flavell and Greenberg,
2008). By performing a series of genome-wide analyses in hippo-
campal neurons at the time that synapses are developing, we
were able to effectively identify over 180 activity-regulated
MEF2 target genes that are primarily expressed in the CNS.
While previous studies have utilized loss- and gain-of-function
experiments to suggest that MEF2 regulates synapse develop-
ment, it has been difficult to distinguish between the direct func-
tions of MEF2 (mediated by its target genes) and the homeostatic
changes that occur in cells where the expression of MEF2 has
been altered for several days. The set of MEF2 targets identified
in our study is enriched for genes whose protein products are
localized to synapses and these genes control multiple aspects
of synaptic function. Thus, the identification of this set of MEF2
targets provides evidence that MEF2 plays a key role in medi-
ating many aspects of synapse and neural circuit development.
One issue left unresolved by this study is which of the newly
identified MEF2 target genes that have not yet been shown to
play a critical role in synapse development are actually involved
in this process. To address this issue, each of the MEF2-
regulated genes will need to be individually tested for their role
in synapse development. The MEF2 target genes that are known
to harbor mutations and polymorphisms in the human population
that lead to an increased susceptibility to neurological disorders
such as epilepsy and autism spectrum disorders (lgi1, arhgef9,
kcna1, ube3a, slc9a6, pcdh10, c3orf58) are especially important
to test for their potential roles in synapse development. The
observation that several activity-dependent MEF2 target genes
are mutated in cases of epilepsy and autism suggests that these
disorders may be caused at least in part by the disruption of
important components of the activity-regulated MEF2 genetic
program that controls neural circuit development.
Our approach to MEF2 target gene identification also revealed
an important feature of the activity-dependent genetic program.
Neuronal activity promotes the use of alternative sites of polyA
addition at many of the MEF2 target genes, which results in
the activity-dependent production of truncated mRNAs and in
some cases truncated proteins (Figure 5E). In cases where
activity-dependent polyA site switching leads to truncated
proteins, these proteins are frequently predicted to act domi-
nantly to alter the function of preexisting full-length proteins. In
other cases where activity-dependent polyA site switching leads
to shortened mRNAs that contain full-length open reading
frames but shortened 30 UTRs, this switch will not alter protein
function but instead will likely alter when and where the mRNAsuron 60, 1022–1038, December 26, 2008 ª2008 Elsevier Inc. 1035
Neuron
Genomic Analysis of MEF2 Targetsare translated. We hypothesize that stimulus-dependent
changes in polyadenylation site usage may thus provide a mech-
anism to acutely alter gene function in response to changes in
a cell’s extracellular environment.
It is likely that the genomic approaches that we have used
to study MEF2 function in neurons can be generally applied to
elucidate the gene expression programs that control different
aspects of neural development. In addition, the further charac-
terization of stimulus-regulated transcriptional programs in
neurons and other cell types should provide new insights into
the importance of polyA site switching in stimulus-dependent
transcriptional control and should more generally reveal the
molecular mechanisms by which extracellular factors induce
complex cellular responses that allow multi-cellular organisms
to adapt to changes in their environment.
EXPERIMENTAL PROCEDURES
Cell Culture
Hippocampal neurons from E18 Long-Evans rats were isolated as previously
described (Xia et al., 1996). Detailed information about cell culture conditions,
lentiviral vectors, and pharmacological agents is available in Supplemental
Data.
Plasmids
MEF2A and MEF2D shRNA constructs were previously described (Flavell
et al., 2006). Descriptions of the plasmids encoding MEF2-VP16-ER and the
bdnf luciferase reporter plasmids are available in the Supplemental Data.
Exposure of Rats to Novel Environment
Novel environment experiments were conducted using standard procedures.
Details are available in Supplemental Data.
Mouse Visual Cortex Stimulation
Detailed protocols for mouse visual stimulation and visual cortex isolation are
available in Supplemental Data.
mRNA Profiling Microarray Analyses
For expression profiling of cultured neurons, three biological replicates of each
experiment were performed. For the novel environment experiment, RNA was
collected from six animals for each experimental condition. Arrays from all
experimental conditions (and all replicates) of a given experiment were
normalized to one another and all subsequent analyses were conducted using
GeneSpring GX software (Agilent, Santa Clara, CA). Additional details about
RNA isolation, sample preparation and array analysis methods are available
in Supplemental Data.
Identification of Multiple Probe Sets Mapping to Individual Genes
To identify cases where multiple probe sets mapping to the same gene
showed different expression profiles, we used standard procedures that are
described in detail in Supplemental Data.
Statistical Analyses and Comparisons
Statistical methods used to investigate MEF2 target gene expression in
different tissues (through GNF Atlas 2 data), as well as details about Ingenuity
Pathway analyses, are available in Supplemental Data.
Reverse Transcription-Quantitative PCR
All RT-qPCR experiments were performed essentially as previously described
(Flavell et al., 2006). Details are available in Supplemental Data.
Luciferase Assays
All luciferase assays were performed essentially as previously described
(Flavell et al., 2006). Details are available in Supplemental Data.1036 Neuron 60, 1022–1038, December 26, 2008 ª2008 Elsevier IncAntibodies
The antibodies used in all experiments are described in Supplemental Data.
Chromatin Immunoprecipitation
Typically 20–40 million hippocampal neurons were used for a single ChIP
experiment. A detailed description of the ChIP procedure is available in
Supplemental Data.
Quantitative-PCR Using ChIP Samples
ChIP analyses of all individual genomic regions were conducted using qPCR
and are described in Supplemental Data.
ChIP-Chip
The arrays used for ChIP-chip were manufactured by Nimblegen Systems, Inc
(Madison, WI). We performed two biological replicates of each ChIP-chip
experiment, which included three different stimulation conditions (unstimu-
lated, 20 and 140 min after KCl depolarization). Furthermore, each ChIP exper-
iment was paired with a negative control ChIP reaction that was performed
with a negative control antibody. For MEF2D ChIP, the negative control anti-
body was a MEF2D antibody that was preblocked with antigen peptide. For
RNA Polymerase II ChIP, mouse IgG mix (Santa Cruz Biotechnology, Inc)
was used as a negative control. Details about microarrays and ChIP-chip
library preparation are available in Supplemental Data.
ChIP-Chip Data Analysis
Signal intensity data was extracted from the scanned images of each array
using NimbleScan, NimbleGen’s data extraction software. Subsequently,
scaled log2-ratio values from each probe were obtained (log2[ChIP signal
intensity/input signal intensity]). The log2-ratio was computed and scaled to
center these values around zero. Scaling was performed by subtracting the
bi-weight mean for the log2-ratio values for all features on the array from
each log2-ratio value. We then identified regions of MEF2D and RNA poly-
merase II occupancy using a custom-written ChIP-chip data analysis program
that was implemented using the R language and is composed of three parts
that are described in Supplemental Data.
Bioinformatic Analyses
Methods used to investigate evolutionary conservation and sequence motifs
within the rodent genome are described in Supplemental Data.
SUPPLEMENTAL DATA
The Supplemental Data include figures and Experimental Procedures and can
be found with this article online at http://www.neuron.org/supplemental/
S0896-6273(08)01050-7.
ACKNOWLEDGMENTS
We thank members of the Greenberg lab for their helpful suggestions and
discussions and for critical reading of the manuscript. In particular, we thank
J. Zieg for assistance with figures and S. Vasquez for preparing primary
neuronal cell cultures. We thank the Molecular Genetics Core Facility at Chil-
dren’s Hospital Boston for assistance with microarrays. We also thank Soren
Impey and Richard H. Goodman for their early guidance concerning genome-
wide applications of ChIP and Gabriel Kreiman for bioinformatics help. M.E.G.
acknowledges the generous support of the Nancy Lurie Marks Family Founda-
tion and the generous support of the F.M. Kirby Foundation to the F.M. Kirby
Neurobiology Center of Children’s Hospital Boston. This work was supported
by a Jane Coffin Childs Memorial Fund postdoctoral fellowship (T.K.K), a Lefler
postdoctoral fellowship (T.K.K.), a Helen Hay Whitney postdoctoral fellowship
(J.M.G.), a National Library of Medicine training fellowship in Biomedical Infor-
matics (D.A.H.), Developmental Disability Research Center grant HD18655
and National Institutes of Health grant NS028829 (M.E.G.).
Accepted: November 13, 2008
Published: December 24, 2008.
Neuron
Genomic Analysis of MEF2 TargetsREFERENCES
Aizawa, H., Hu, S.C., Bobb, K., Balakrishnan, K., Ince, G., Gurevich, I., Cowan,
M., and Ghosh, A. (2004). Dendrite development regulated by CREST,
a calcium-regulated transcriptional activator. Science 303, 197–202.
Barbosa, A.C., Kim, M.S., Ertunc, M., Adachi, M., Nelson, E.D., McAnally, J.,
Richardson, J.A., Kavalali, E.T., Monteggia, L.M., Bassel-Duby, R., et al.
(2008). MEF2C, a transcription factor that facilitates learning and memory by
negative regulation of synapse numbers and function. Proc. Natl. Acad. Sci.
USA 105, 9391–9396.
Barco, A., Alarcon, J.M., and Kandel, E.R. (2002). Expression of constitutively
active CREB protein facilitates the late phase of long-term potentiation by
enhancing synaptic capture. Cell 108, 689–703.
Boehm, S., and Betz, H. (1997). Somatostatin inhibits excitatory transmission
at rat hippocampal synapses via presynaptic receptors. J. Neurosci. 17,
4066–4075.
Chen, C., and Regehr, W.G. (2000). Developmental remodeling of the retinoge-
niculate synapse. Neuron 28, 955–966.
Chowdhury, S., Shepherd, J.D., Okuno, H., Lyford, G., Petralia, R.S., Plath, N.,
Kuhl, D., Huganir, R.L., and Worley, P.F. (2006). Arc/Arg3.1 interacts with
the endocytic machinery to regulate AMPA receptor trafficking. Neuron 52,
445–459.
Dibbens, L.M., Tarpey, P.S., Hynes, K., Bayly, M.A., Scheffer, I.E., Smith, R.,
Bomar, J., Sutton, E., Vandeleur, L., Shoubridge, C., et al. (2008). X-linked pro-
tocadherin 19 mutations cause female-limited epilepsy and cognitive impair-
ment. Nat. Genet. 40, 776–781.
Etkin, A., Alarcon, J.M., Weisberg, S.P., Touzani, K., Huang, Y.Y., Nordheim,
A., and Kandel, E.R. (2006). A role in learning for SRF: deletion in the adult fore-
brain disrupts LTD and the formation of an immediate memory of a novel
context. Neuron 50, 127–143.
Flavell, S.W., and Greenberg, M.E. (2008). Signaling mechanisms linking
neuronal activity to gene expression and plasticity of the nervous system.
Annu. Rev. Neurosci. 31, 563–590.
Flavell, S.W., Cowan, C.W., Kim, T.K., Greer, P.L., Lin, Y., Paradis, S., Griffith,
E.C., Hu, L.S., Chen, C., and Greenberg, M.E. (2006). Activity-dependent regu-
lation of MEF2 transcription factors suppresses excitatory synapse number.
Science 311, 1008–1012.
Fleischmann, A., Hvalby, O., Jensen, V., Strekalova, T., Zacher, C., Layer, L.E.,
Kvello, A., Reschke, M., Spanagel, R., Sprengel, R., et al. (2003). Impaired
long-term memory and NR2A-type NMDA receptor-dependent synaptic plas-
ticity in mice lacking c-Fos in the CNS. J. Neurosci. 23, 9116–9122.
Fukata, Y., Adesnik, H., Iwanaga, T., Bredt, D.S., Nicoll, R.A., and Fukata, M.
(2006). Epilepsy-related ligand/receptor complex LGI1 and ADAM22 regulate
synaptic transmission. Science 313, 1792–1795.
Gaudilliere, B., Konishi, Y., de la Iglesia, N., Yao, G., and Bonni, A. (2004).
A CaMKII-NeuroD signaling pathway specifies dendritic morphogenesis.
Neuron 41, 229–241.
Giesemann, T., Schwarz, G., Nawrotzki, R., Berhorster, K., Rothkegel, M.,
Schluter, K., Schrader, N., Schindelin, H., Mendel, R.R., Kirsch, J., and Jock-
usch, B.M. (2003). Complex formation between the postsynaptic scaffolding
protein gephyrin, profilin, and Mena: a possible link to the microfilament
system. J. Neurosci. 23, 8330–8339.
Gromak, N., West, S., and Proudfoot, N.J. (2006). Pause sites promote tran-
scriptional termination of mammalian RNA polymerase II. Mol. Cell. Biol. 26,
3986–3996.
Hiroi, N., Brown, J.R., Haile, C.N., Ye, H., Greenberg, M.E., and Nestler, E.J.
(1997). FosB mutant mice: loss of chronic cocaine induction of Fos-related
proteins and heightened sensitivity to cocaine’s psychomotor and rewarding
effects. Proc. Natl. Acad. Sci. USA 94, 10397–10402.
Hua, J.Y., and Smith, S.J. (2004). Neural activity and the dynamics of central
nervous system development. Nat. Neurosci. 7, 327–332.
Impey, S., McCorkle, S.R., Cha-Molstad, H., Dwyer, J.M., Yochum, G.S.,
Boss, J.M., McWeeney, S., Dunn, J.J., Mandel, G., and Goodman, R.H.N(2004). Defining the CREB regulon: a genome-wide analysis of transcription
factor regulatory regions. Cell 119, 1041–1054.
Ince-Dunn, G., Hall, B.J., Hu, S.C., Ripley, B., Huganir, R.L., Olson, J.M.,
Tapscott, S.J., and Ghosh, A. (2006). Regulation of thalamocortical patterning
and synaptic maturation by NeuroD2. Neuron 49, 683–695.
Jones, M.W., Errington, M.L., French, P.J., Fine, A., Bliss, T.V., Garel, S.,
Charnay, P., Bozon, B., Laroche, S., and Davis, S. (2001). A requirement for
the immediate early gene Zif268 in the expression of late LTP and long-term
memories. Nat. Neurosci. 4, 289–296.
Kanai, Y., Dohmae, N., and Hirokawa, N. (2004). Kinesin transports RNA: isola-
tion and characterization of an RNA-transporting granule. Neuron 43, 513–525.
Kim, T.G., Jung, J., Mysliwiec, M.R., Kang, S., and Lee, Y. (2005). Jumonji
represses alpha-cardiac myosin heavy chain expression via inhibiting MEF2
activity. Biochem. Biophys. Res. Commun. 329, 544–553.
Li, L., Yun, S.H., Keblesh, J., Trommer, B.L., Xiong, H., Radulovic, J., and
Tourtellotte, W.G. (2007). Egr3, a synaptic activity regulated transcription
factor that is essential for learning and memory. Mol. Cell. Neurosci. 35, 76–88.
Lin, Y., Bloodgood, B.L., Hauser, J.L., Lapan, A.D., Koon, A.C., Kim, T.K., Hu,
L.S., Malik, A.N., and Greenberg, M.E. (2008). Activity-dependent regulation of
inhibitory synapse development by Npas4. Nature 455, 1198–1204.
Lujan, R., de Cabo de la Vega, C., Dominguez del Toro, E., Ballesta, J.J.,
Criado, M., and Juiz, J.M. (2003). Immunohistochemical localization of the
voltage-gated potassium channel subunit Kv1.4 in the central nervous system
of the adult rat. J. Chem. Neuroanat. 26, 209–224.
Majdan, M., and Shatz, C.J. (2006). Effects of visual experience on activity-
dependent gene regulation in cortex. Nat. Neurosci. 9, 650–659.
Malinow, R., and Malenka, R.C. (2002). AMPA receptor trafficking and
synaptic plasticity. Annu. Rev. Neurosci. 25, 103–126.
McKinsey, T.A., Zhang, C.L., Lu, J., and Olson, E.N. (2000). Signal-dependent
nuclear export of a histone deacetylase regulates muscle differentiation.
Nature 408, 106–111.
Micheli, L., Leonardi, L., Conti, F., Buanne, P., Canu, N., Caruso, M., and
Tirone, F. (2005). PC4 coactivates MyoD by relieving the histone deacetylase
4-mediated inhibition of myocyte enhancer factor 2C. Mol. Cell. Biol. 25,
2242–2259.
Mikkelsen, T.S., Ku, M., Jaffe, D.B., Issac, B., Lieberman, E., Giannoukos, G.,
Alvarez, P., Brockman, W., Kim, T.K., Koche, R.P., et al. (2007). Genome-wide
maps of chromatin state in pluripotent and lineage-committed cells. Nature
448, 553–560.
Morrow, E.M., Yoo, S.Y., Flavell, S.W., Kim, T.K., Lin, Y., Hill, R.S., Mukaddes,
N.M., Balkhy, S., Gascon, G., Hashmi, A., et al. (2008). Identifying autism Loci
and genes by tracing recent shared ancestry. Science 321, 218–223.
Nithianantharajah, J., and Hannan, A.J. (2006). Enriched environments,
experience-dependent plasticity and disorders of the nervous system. Nat.
Rev. Neurosci. 7, 697–709.
Papadopoulos, T., Korte, M., Eulenburg, V., Kubota, H., Retiounskaia, M., Har-
vey, R.J., Harvey, K., O’Sullivan, G.A., Laube, B., Hulsmann, S., et al. (2007).
Impaired GABAergic transmission and altered hippocampal synaptic plasticity
in collybistin-deficient mice. EMBO J. 26, 3888–3899.
Potthoff, M.J., and Olson, E.N. (2007). MEF2: a central regulator of diverse
developmental programs. Development 134, 4131–4140.
Pulipparacharuvil, S., Renthal, W., Hale, C.F., Taniguchi, M., Xiao, G., Kumar,
A., Russo, S.J., Sikder, D., Dewey, C.M., Davis, M.M., et al. (2008). Cocaine
regulates MEF2 to control synaptic and behavioral plasticity. Neuron 59,
621–633.
Raab-Graham, K.F., Haddick, P.C., Jan, Y.N., and Jan, L.Y. (2006). Activity-
and mTOR-dependent suppression of Kv1.1 channel mRNA translation in
dendrites. Science 314, 144–148.
Ramanan, N., Shen, Y., Sarsfield, S., Lemberger, T., Schutz, G., Linden, D.J.,
and Ginty, D.D. (2005). SRF mediates activity-induced gene expression and
synaptic plasticity but not neuronal viability. Nat. Neurosci. 8, 759–767.euron 60, 1022–1038, December 26, 2008 ª2008 Elsevier Inc. 1037
Neuron
Genomic Analysis of MEF2 TargetsRenthal, W., Maze, I., Krishnan, V., Covington, H.E., 3rd, Xiao, G., Kumar, A.,
Russo, S.J., Graham, A., Tsankova, N., Kippin, T.E., et al. (2007). Histone
deacetylase 5 epigenetically controls behavioral adaptations to chronic
emotional stimuli. Neuron 56, 517–529.
Roberto, M., Scuri, R., and Brunelli, M. (2001). Differential effects of PACAP-38
on synaptic responses in rat hippocampal CA1 region. Learn. Mem. 8,
265–271.
Rutherford, L.C., DeWan, A., Lauer, H.M., and Turrigiano, G.G. (1997).
Brain-derived neurotrophic factor mediates the activity-dependent regulation
of inhibition in neocortical cultures. J. Neurosci. 17, 4527–4535.
Sala, C., Futai, K., Yamamoto, K., Worley, P.F., Hayashi, Y., and Sheng, M.
(2003). Inhibition of dendritic spine morphogenesis and synaptic transmission
by activity-inducible protein Homer1a. J. Neurosci. 23, 6327–6337.
Sandberg, R., Neilson, J.R., Sarma, A., Sharp, P.A., and Burge, C.B. (2008).
Proliferating cells express mRNAs with shortened 30 untranslated regions
and fewer microRNA target sites. Science 320, 1643–1647.
Shalizi, A., Gaudilliere, B., Yuan, Z., Stegmuller, J., Shirogane, T., Ge, Q., Tan,
Y., Schulman, B., Harper, J.W., and Bonni, A. (2006). A calcium-regulated
MEF2 sumoylation switch controls postsynaptic differentiation. Science 311,
1012–1017.
Simon, D.J., Madison, J.M., Conery, A.L., Thompson-Peer, K.L., Soskis, M.,
Ruvkun, G.B., Kaplan, J.M., and Kim, J.K. (2008). The microRNA miR-1
regulates a MEF-2-dependent retrograde signal at neuromuscular junctions.
Cell 133, 903–915.
Su, A.I., Wiltshire, T., Batalov, S., Lapp, H., Ching, K.A., Block, D., Zhang, J.,
Soden, R., Hayakawa, M., Kreiman, G., et al. (2004). A gene atlas of the mouse1038 Neuron 60, 1022–1038, December 26, 2008 ª2008 Elsevier Incand human protein-encoding transcriptomes. Proc. Natl. Acad. Sci. USA 101,
6062–6067.
Tian, B., Hu, J., Zhang, H., and Lutz, C.S. (2005). A large-scale analysis of
mRNA polyadenylation of human and mouse genes. Nucleic Acids Res. 33,
201–212.
Wang, H., Pineda, V.V., Chan, G.C., Wong, S.T., Muglia, L.J., and Storm, D.R.
(2003). Type 8 adenylyl cyclase is targeted to excitatory synapses and required
for mossy fiber long-term potentiation. J. Neurosci. 23, 9710–9718.
Xia, Z., Dudek, H., Miranti, C.K., and Greenberg, M.E. (1996). Calcium influx via
the NMDA receptor induces immediate early gene transcription by a MAP
kinase/ERK-dependent mechanism. J. Neurosci. 16, 5425–5436.
Yasuda, S., Tanaka, H., Sugiura, H., Okamura, K., Sakaguchi, T., Tran, U.,
Takemiya, T., Mizoguchi, A., Yagita, Y., Sakurai, T., et al. (2007). Activity-
induced protocadherin arcadlin regulates dendritic spine number by triggering
N-cadherin endocytosis via TAO2beta and p38 MAP kinases. Neuron 56,
456–471.
Youn, H.D., Chatila, T.A., and Liu, J.O. (2000). Integration of calcineurin and
MEF2 signals by the coactivator p300 during T-cell apoptosis. EMBO J. 19,
4323–4331.
Zhang, X., and Poo, M.M. (2002). Localized synaptic potentiation by BDNF
requires local protein synthesis in the developing axon. Neuron 36, 675–688.
Zhu, Y., Pak, D., Qin, Y., McCormack, S.G., Kim, M.J., Baumgart, J.P.,
Velamoor, V., Auberson, Y.P., Osten, P., van Aelst, L., et al. (2005). Rap2-
JNK removes synaptic AMPA receptors during depotentiation. Neuron 46,
905–916..
